Indian pharma faces headwinds of US pricing reform & Europe’s HTA-driven cost-effectiveness: Akash Kedia
The Indian pharmaceutical industry is currently navigating a challenging landscape shaped by US pricing reforms and Europe's increasing reliance on HTA (Health Technology Assessment) frameworks. India remains a global powerhouse in generics and …